Study demonstrates potential of new gene vector to broaden treatment of eye diseases

June 22, 2011 in Medical research

Next generation gene therapy

Enlarge

Green fluorescent protein in photoreceptors and retinal pigment epithelial cells after subretinal injection of AAV8 in a monkey retina. Cell nuclei are labeled blue and cone photoreceptors are labeled red. Credit: Luk Vanderberghe, Ph.D., Perelman School of Medicine at the University of Pennsylvania

Inspired by earlier successes using gene therapy to correct an inherited type of blindness, investigators from the Perelman School of Medicine at the University of Pennsylvania, are poised to extend their approach to other types of blinding disorders.

In a previous human trial conducted at the Children's Hospital of Philadelphia and Penn, researchers packaged a normal version of a gene missing in Leber's congenital amaurosis (LCA) inside a genetically engineered vector, called an adeno-associated virus (AAV). The vector delivered the gene to cells in the , where the gene produces an enzyme that restores light receptors.

"The results from three Phase I clinical trials for LCA showed the potential for gene therapy based on adeno-associated viruses delivering corrective to the retina," notes co-senior author Jean Bennett, MD, PhD, the F.M. Kirby professor of Ophthalmology. "To broaden treating inherited eye diseases, we will need a larger vector toolkit, and what we have seen of AAV8 gives us hope for creating gene therapies for diseases that attack the retina's photoreceptors. This preclinical study provides the guidance we need to formulate dose level and type of vector to deliver corrective genes to treat blindness caused by the loss of photoreceptors."

In the present study, published in this week, the Penn team compared the safety and efficiency of delivery in an animal model of two different types of AAVs - AAV2, which was used in the human trials for LCA, and AAV8, a second-generation AAV technology initially discovered in the lab of co-senior author James M. Wilson, MD, PhD, professor of Pathology and Laboratory Medicine.

The researchers used both vectors to deliver a (GFP) transgene to the epithelial (RPE) cells and photoreceptor cells of nonhuman primates. Photoreceptor cells are the problem area for other retinal diseases such as (RP) and others, for which there is no treatment. Photoreceptors are specialized nerve cells that convert light into a biological electrical signal and are designated as rods and cones.

"We showed that we can use AAV8 to deliver genes to the photoreceptor of the primate eye at lower doses, both safely and efficiently," says first author Luk H. Vandenberghe, PhD, Senior Investigator, Gene Therapy Program, and currently at Penn's F.M. Kirby Center for Molecular Ophthalmology.

Both AAV2 and AAV8 delivered the gene safely and efficiently to the monkey retinas, but AAV8 was markedly better at targeting .

The STM study describes the dose relationship between AAV2 and AAV8 vectors and their target cells and the immune response in the nonhuman primate retina. From this the researchers found dosage thresholds to safely and efficiently target cells in the outer retina such as RPE cells and rod and cone photoreceptors. While AAV2 and AAV8 efficiently delivered the gene to at moderate to low doses, expression of the GFP gene in rod and cone photoreceptors was reached only at higher dosages. Substantial delivery to rods was obtained with moderate doses of AAV8, doses similar to those currently used in experimental clinical protocols.

The vectors at intermediate doses did not cause problematic immune responses and post-surgical injection complications. The delivered gene also stayed in the retina at very high levels throughout the study duration of four months. Additionally, the GFP gene was preferentially transduced to one type of retinal ganglion cells, which surprised the researchers. In general retinal ganglion transmit visual information from the retina to several regions of the brain. This knowledge could be used in the future to further delineate the neuronal connections between the retina and the brain.

In earlier animal studies, AAV8 also delivered genes safely and efficiently to the mouse retina. However, the mouse retina differs significantly from the primate retina, most notably in structure, which affects the surgical approach to delivering corrective genes to different parts of the eye. (For example, mice do not have a macula – the eye structure used for visual discrimination, which is affected in macular degeneration – and primates do.) The present study in nonhuman primates is the next step to better translate treatment strategies for people.

"To address patients with other retinal diseases, we need a renaissance of technology--new and better vectors to safely and effectively deliver corrective genes to a range of diseases," says Wilson. "My lab has recently isolated new families of simian-based adenoviruses and adeno-associated viruses. Recombinant versions of these viruses are turning out to be useful as improved gene transfer vehicles to a variety of targets."

Provided by University of Pennsylvania search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Computational tool translates complex data into simplified 2-dimensional images

In their quest to learn more about the variability of cells between and within tissues, biomedical scientists have devised tools capable of simultaneously measuring dozens of characteristics of individual ...

Medical research created 11 hours ago | popularity 5 / 5 (2) | comments 0 | with audio podcast

Now we know why old scizophrenia medicine works on antibiotics-resistant bacteria

In 2008 researchers from the University of Southern Denmark showed that the drug thioridazine, which has previously been used to treat schizophrenia, is also a powerful weapon against antibiotic-resistant bacteria such as ...

Medical research created May 17, 2013 | popularity 4 / 5 (4) | comments 0 | with audio podcast

SUMO wrestling cells reveal new protective mechanism target for stroke

Scientists investigating the interaction of a group of proteins in the brain responsible for protecting nerve cells from damage have identified a new target that could increase cell survival.

Medical research created May 17, 2013 | popularity 5 / 5 (1) | comments 0

How serotonin receptors can shape drug effects, from LSD to migraine medication

New findings by researchers carrying out experiments at the U.S. Department of Energy Office of Science's Advanced Photon Source (APS) help explain why some drugs that interact with two kinds of human serotonin ...

Medical research created May 17, 2013 | popularity 4 / 5 (1) | comments 0 | with audio podcast

Preventing blood poisoning

Peptide molecules derived from the body's natural immune system can help boost the body's defence against life-threatening blood poisoning, joint University research has uncovered.

Medical research created May 17, 2013 | popularity 4 / 5 (1) | comments 0 | with audio podcast


Researchers identify a potential new risk for sleep apnea: Asthma

Researchers at the University of Wisconsin have identified a potential new risk factor for obstructive sleep apnea: asthma. Using data from the National Institutes of Health (Heart, Lung, and Blood Institute)-funded Wisconsin ...

New theory on genesis of osteoarthritis comes with successful therapy in mice

Scientists at Johns Hopkins have turned their view of osteoarthritis (OA) inside out. Literally. Instead of seeing the painful degenerative disease as a problem primarily of the cartilage that cushions joints, ...

Study finds that sleep apnea and Alzheimer's are linked

A new study looking at sleep-disordered breathing (SDB) and markers for Alzheimer's disease (AD) risk in cerebrospinal fluid (CSF) and neuroimaging adds to the growing body of research linking the two.

'Gap' for HIV vaccine efforts after latest setback

The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.

Ginger compounds may be effective in treating asthma symptoms

Gourmands and foodies everywhere have long recognized ginger as a great way to add a little peppery zing to both sweet and savory dishes; now, a study from researchers at Columbia University shows purified components of the ...

Ketamine shows significant therapeutic benefit in people with treatment-resistant depression

Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the ...